SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Nutraceutix(nutx .96) inhibits lung cancer! News story
NUTX 121.34-7.5%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rite Aid who wrote (15)5/5/1998 10:34:00 AM
From: Moosie  Read Replies (2) of 57
 
News
REDMOND, Wash., May 5 /PRNewswire/ -- Nutraceutix, Inc. (OTC Bulletin Board: NUTX - news), a developer and manufacturer of health supplements, today introduced its BioPower(R) retail website (WWW.BIOPOWR.COM), exclusively
selling its new BioPower(R) supplement line. Nutraceutix's BioPower(R) products features Glucarate, its patented health
supplement that nutritionally supports the removal of carcinogens from the body. This is the first time that Nutraceutix is
offering its products directly to the consumer. BioPower(R) is not otherwise being sold retail.

''We are proud that our website reflects the same advanced technology that our products do,'' commented William D. St.
John, chairman and president of Nutraceutix. ''Less than 1% of the 1.9 million websites are currently secure- commerce
enabled, and we have gone beyond the industry standard for online security with 'secure socket layer protocol' and 'valid
certificates. The web is ideal for reaching out to consumers of health supplements, who are extremely current and informed
people.'''

The BioPower(R) Website offers a line of Nutraceutix's supplements, including: Acidophilus Plus, Calcium D-glucarate for
breast health, Colactin, Calcium D-glucarate for lung health, Echinacea, Ginkgo Biloba, St. John's Wort, Vitamin C with
Bioflavanoids, and Vitamin E. The Company expects that more products will be offered in the future.

Nutraceutix, Inc. develops, licenses and manufactures proprietary and non- proprietary private-label health supplements and
related products for major health supplement companies, with distribution to health food and retail mass merchants. The
Company holds patents on technologies with exclusive multi- year licensing and manufacturing agreements with such major
nutritional companies as Weider Nutrition International, mass-marketer of Schiff(R) and NuStart(TM) products containing
Nutraceutix's patented compound Glucarate, which nutritionally supports the removal of carcinogens from the body.
Nutraceutix owns the exclusive worldwide license to manufacture and formulate products containing calcium D-glucarate,
which was developed by researchers at the M.D. Anderson Cancer Center at the University of Texas and has been shown to
naturally support the body's mechanisms for eliminating carcinogens. Nutraceutix developed and manufactures its proprietary
LIVEBAC(R) health supplements, which are also sold under the Schiff(R) and other brand names.

Nutraceutix is headquartered at its operating facility in Redmond, WA, with an additional manufacturing and packaging
operation located outside of Denver, CO. The Company also conducts research and development for the continued
development of new food supplements for humans and livestock at its wholly owned Bio Techniques Laboratories subsidiary,
based in Redmond, WA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext